EMA — authorised 5 November 2020
- Marketing authorisation holder: AstraZeneca AB
- Status: approved
🇪🇺 Calquence in European Union
EMA authorised Calquence on 5 November 2020
Marketing authorisation
Calquence in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Calquence approved in European Union?
Yes. EMA authorised it on 5 November 2020.
Who is the marketing authorisation holder for Calquence in European Union?
AstraZeneca AB holds the EU marketing authorisation.